Position in LLY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,987,455
+$570,090 QoQ
Shares Held
1,657
+7.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,507
of 4,605 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirador Capital Partners LP holds $28,463,151 across 9 Drug Manufacturers - General names. LLY ranks #3 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,762 | $17,303,269 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
48,795 | $2,811,567 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,657 | $1,987,455 | |
| 4 | JNJ |
Johnson & Johnson
|
7,410 | $1,881,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,099 | $1,781,267 | |
| 6 | PFE |
Pfizer Inc
|
45,835 | $1,103,706 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,882 | $755,837 | |
| 8 | AMGN |
Amgen Inc
|
1,410 | $510,589 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,987,455 | 1,657 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $1,417,365 | 1,541 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,647,484 | 1,533 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,195,621 | 1,567 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,101,475 | 1,413 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,137,278 | 1,377 | Shares | Sole | 2025-04-09 | |
| 2024-03-31 | $1,189,500 | 1,529 | Shares | Sole | 2024-04-18 | |
| 2021-03-31 | $2,976,042 | 15,930 | Shares | Sole | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||